Dow Jones

38,852.86

0.00%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

FBRX

Forte Biosciences (FBRX)

Forte Biosciences Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:FBRX

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
13/05/2024	15:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FBRX	Forte Biosciences Inc
13/05/2024	15:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FBRX	Forte Biosciences Inc
16/02/2024	15:16	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:FBRX	Forte Biosciences Inc
14/02/2024	15:54	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:FBRX	Forte Biosciences Inc
05/01/2024	16:27	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:FBRX	Forte Biosciences Inc
03/01/2024	15:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
14/09/2023	15:00	Edgar (US Regulatory)	Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material	NASDAQ:FBRX	Forte Biosciences Inc
14/09/2023	09:50	Business Wire	ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual Meeting	NASDAQ:FBRX	Forte Biosciences Inc
10/09/2023	23:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:FBRX	Forte Biosciences Inc
08/09/2023	15:36	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:FBRX	Forte Biosciences Inc
06/09/2023	14:15	Business Wire	Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s Boardroom	NASDAQ:FBRX	Forte Biosciences Inc
01/09/2023	16:25	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:FBRX	Forte Biosciences Inc
29/08/2023	16:57	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:FBRX	Forte Biosciences Inc
25/08/2023	09:10	Edgar (US Regulatory)	Form DEFC14A - Definitive proxy statement, contested solicitations	NASDAQ:FBRX	Forte Biosciences Inc
25/08/2023	07:00	Business Wire	Concerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to Stockholders	NASDAQ:FBRX	Forte Biosciences Inc
24/08/2023	05:17	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:FBRX	Forte Biosciences Inc
23/08/2023	15:47	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:FBRX	Forte Biosciences Inc
17/08/2023	08:30	Edgar (US Regulatory)	Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise	NASDAQ:FBRX	Forte Biosciences Inc
09/08/2023	11:23	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:FBRX	Forte Biosciences Inc
02/08/2023	16:28	Edgar (US Regulatory)	Form PREC14A - Preliminary proxy statements, contested solicitations	NASDAQ:FBRX	Forte Biosciences Inc
26/06/2023	16:14	Edgar (US Regulatory)	Amended Securities Registration (section 12(b)) (8-a12b/a)	NASDAQ:FBRX	Forte Biosciences Inc
26/06/2023	15:57	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FBRX	Forte Biosciences Inc
10/04/2023	07:06	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:FBRX	Forte Biosciences Inc
31/03/2023	15:37	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:FBRX	Forte Biosciences Inc
31/03/2023	15:04	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:FBRX	Forte Biosciences Inc
29/03/2023	10:18	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:FBRX	Forte Biosciences Inc
23/03/2023	15:18	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FBRX	Forte Biosciences Inc
12/01/2023	15:04	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:FBRX	Forte Biosciences Inc
14/11/2022	15:09	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:FBRX	Forte Biosciences Inc
17/08/2022	07:00	Business Wire	Camac Partners Condemns Forte Biosciences’ Seemingly Defensive and Unjustifiable Capital Raise	NASDAQ:FBRX	Forte Biosciences Inc